The Cost Crisis of Weight Loss Drugs

This chapter examines the high costs and accessibility challenges of blockbuster weight loss drugs like Ozempic, highlighting significant price disparities in the U.S. compared to generics. A health economist reveals that production costs are much lower than market prices, prompting a discussion about the impact on patients and the healthcare system.